Cargando…

Loss of Wave1 gene defines a subtype of lethal prostate cancer

Genetic alterations involving TMPRSS2-ERG alterations and deletion of key tumor suppressor genes are associated with development and progression of prostate cancer (PCa). However, less defined are early events that may contribute to the development of high-risk metastatic prostate cancer. Bioinforma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sowalsky, Adam G., Sager, Rebecca, Schaefer, Rachel J., Bratslavsky, Gennady, Pandolfi, Pier Paolo, Balk, Steven P., Kotula, Leszek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494945/ https://www.ncbi.nlm.nih.gov/pubmed/25906751

Ejemplares similares

Structure and Function of the Nuclear Receptor Superfamily and Current Targeted Therapies of Prostate Cancer
por: Porter, Baylee A., et al.
Publicado: (2019)

In Vivo Models for Prostate Cancer Research
por: Adamiecki, Robert, et al.
Publicado: (2022)

Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling
por: Nath, Disharee, et al.
Publicado: (2019)

Novel Target Opportunities in Non-Metastatic Castrate Resistant Prostate Cancer
por: Gleicher, Stephanie, et al.
Publicado: (2021)

Sporadic renal angiomyolipoma in a patient with Birt-Hogg-Dubé: chaperones in pathogenesis
por: Sager, Rebecca A., et al.
Publicado: (2018)

Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal Disease
por: Walker, Simon R., et al.
Publicado: (2021)

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones
por: Hasan, A. M. Mahedi, et al.
Publicado: (2023)

Transrectal Ultrasound in Prostate Cancer: Current Utilization, Integration with mpMRI, HIFU and Other Emerging Applications
por: Panzone, John, et al.
Publicado: (2022)

An Unusual Etiology of Urinary Retention – Small Cell Prostate Carcinoma
por: Li, Guanqun, et al.
Publicado: (2016)

ABI1‐based expression signature predicts breast cancer metastasis and survival
por: Regua, Angelina, et al.
Publicado: (2022)

Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype
por: Han, Hyunho, et al.
Publicado: (2021)

Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race
por: Kensler, Kevin H., et al.
Publicado: (2022)

Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity
por: Woodford, Mark R., et al.
Publicado: (2019)

Decreasing the indications for radical nephrectomy: a study of multifocal renal cell carcinoma
por: Sorbellini, Maximiliano, et al.
Publicado: (2012)

Transcriptional mediators of treatment resistance in lethal prostate cancer
por: He, Meng Xiao, et al.
Publicado: (2021)

High Serine-arginine Protein Kinase 1 Expression with PTEN Loss Defines Aggressive Phenotype of Prostate Cancer Associated with Lethal Outcome and Decreased Overall Survival
por: Abou-Ouf, Hatem, et al.
Publicado: (2020)

A specialized Hsp90 co-chaperone network regulates steroid hormone receptor response to ligand
por: Backe, Sarah J., et al.
Publicado: (2022)

Battling the two-headed dragon of prostate cancer targeted therapy
por: Wilkinson, Scott, et al.
Publicado: (2020)

Genetically Defined Subtypes of Somatostatin-Containing Cortical Interneurons
por: Hostetler, Rachel E., et al.
Publicado: (2023)

Genetically Defined Subtypes of Somatostatin-Containing Cortical Interneurons
por: Hostetler, Rachel E., et al.
Publicado: (2023)

Investigation of androgen receptor-dependent alternative splicing has identified a unique subtype of lethal prostate cancer
por: Seltzer, Sean, et al.
Publicado: (2022)

Reciprocal regulation of Abl kinase by Crk Y251 and Abi1 controls invasive phenotypes in glioblastoma
por: Kumar, Sushil, et al.
Publicado: (2015)

The clinical utility of testicular cancer risk loci
por: Kratz, Christian P, et al.
Publicado: (2011)

Surgical Insights for the Management of Variant Histology in Renal Cell Carcinoma
por: Dispagna, Mauro Antonio, et al.
Publicado: (2021)

Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer
por: Hennigan, S. Thomas, et al.
Publicado: (2019)

Editorial: The development of lethal prostate cancer
por: Zhang, Baotong, et al.
Publicado: (2023)

Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors
por: Einstein, David J., et al.
Publicado: (2021)

The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes
por: Pellett, Sabine, et al.
Publicado: (2018)

Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
por: Mao, Ninghui, et al.
Publicado: (2021)

Comment on: Intratumor heterogeneity and clonal evolution revealed in castration-resistant prostate cancer by longitudinal genomic analysis by Jing Li et al.
por: Wilkinson, Scott, et al.
Publicado: (2022)

Applications of Focused Ultrasound in the Treatment of Genitourinary Cancers
por: Panzone, John, et al.
Publicado: (2022)

The Current Role of Lymph Node Dissection in Nonmetastatic Localized Renal Cell Carcinoma
por: Ngai, Megan, et al.
Publicado: (2023)

Basal microvilli define the metabolic capacity and lethal phenotype of pancreatic cancer
por: Han, Xu, et al.
Publicado: (2021)

Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer
por: Roa-Peña, Lucia, et al.
Publicado: (2019)

SR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXRα/FOXM1 pathway independently of REV-ERBs
por: Xu, Hang, et al.
Publicado: (2022)

The Evolutionary History of Lethal Metastatic Prostate Cancer
por: Gundem, Gunes, et al.
Publicado: (2015)

Uncertainties in the PET defined A‐/T(Neocortical)+ subtype
por: Mormino, Elizabeth C., et al.
Publicado: (2022)

Defining cellular population dynamics at single-cell resolution during prostate cancer progression
por: Germanos, Alexandre A, et al.
Publicado: (2022)

Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci
por: Fontugne, Jacqueline, et al.
Publicado: (2022)

Sixth BHD Symposium and First International Upstate Kidney Cancer Symposium: latest scientific and clinical discoveries
por: Bratslavsky, Gennady, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0n7l4id8ma7t679d8ahfo308m7